Endocannabinoid-Epigenetic Cross-Talk: A Bridge toward Stress Coping

Area of Science:

• Neuroscience
• Molecular Biology
• Psychiatry

Background:

• Neuropsychiatric disorders are linked to physical and psychological stress.
• The molecular mechanisms underlying stress responses and disease onset remain unclear.
• The endocannabinoid system (ECS) is a key homeostatic pathway involved in managing stress.

Purpose of the Study:

• To review recent findings on the ECS's role in stress coping.
• To highlight the protective functions of 2-arachidonoylglycerol (2-AG) in stress response.
• To explore the interplay between the ECS and epigenetic regulation in stress adaptation.

Main Methods:

• Review of current scientific literature on the endocannabinoid system and stress.
• Analysis of molecular pathways involving glutamate release and cannabinoid receptors.
• Investigation of epigenetic regulation by Lysine Specific Demethylase 1 in stress response.

Main Results:

• The ECS limits excitatory neurotransmission (glutamate release) via 2-AG synthesis and CB1 receptor activation.
• Chronic stress can lead to 2-AG overstimulation and subsequent CB1 receptor desensitization.
• The ECS plays a crucial role in terminating stress responses and promoting stress resilience.

Conclusions:

• The ECS is a vital stress-coping mechanism, but vulnerable to chronic stress-induced desensitization.
• Epigenetic regulation, involving Lysine Specific Demethylase 1, interacts with the ECS to maintain homeostasis.
• Transcriptional homeostasis supports synaptic and behavioral adaptation to reduce the psychiatric impact of trauma.